Rein Therapeutics Inc.
RNTX
$1.76
-$0.15-7.85%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -25.69% | 46.26% | 60.38% | -27.98% | -18.50% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -63.95% | 366.28% | 94.15% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -16.89% | 3,020.00% | 0.00% | 0.00% | 3,712.00% |
Total Current Assets | -25.23% | 46.05% | 65.99% | -25.38% | -16.49% |
|
|||||
Total Current Assets | -25.23% | 46.05% | 65.99% | -25.38% | -16.49% |
Net Property, Plant & Equipment | -94.74% | -96.55% | -94.87% | -88.46% | -82.73% |
Long-term Investments | 0.00% | -- | -- | -- | -- |
Goodwill | 0.00% | -- | -- | -- | -- |
Total Other Intangibles | -46.72% | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -99.91% | -- | -- | -- | 9,037.50% |
Total Assets | -41.33% | 712.80% | 681.93% | 478.14% | 381.70% |
|
|||||
Total Accounts Payable | -23.45% | 122.93% | 475.00% | 370.74% | -30.81% |
Total Accrued Expenses | 60.35% | 303.13% | 293.15% | 49.82% | 102.83% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | 45.45% |
Total Finance Division Other Current Liabilities | -40.78% | 231.82% | 269.57% | -72.74% | 13.81% |
Total Other Current Liabilities | -40.78% | 231.82% | 269.57% | -72.74% | 13.81% |
Total Current Liabilities | 31.11% | 248.46% | 312.45% | 57.14% | 29.58% |
|
|||||
Total Current Liabilities | 31.11% | 248.46% | 312.45% | 57.14% | 29.58% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -38.39% | -- | -- | -- | -- |
Total Liabilities | 1.13% | 453.26% | 600.00% | 172.47% | 127.87% |
|
|||||
Common Stock & APIC | 22.11% | 23.36% | 23.43% | 16.65% | 1.38% |
Retained Earnings | -21.80% | -10.40% | -9.03% | -6.51% | -5.77% |
Treasury Stock & Other | 71.43% | -- | -1,000.00% | -530.00% | -31.25% |
Total Common Equity | 36.30% | 348.54% | 337.83% | 213.53% | -63.02% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -50.77% | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -50.77% | -- | -- | -- | -- |
|
|||||
Total Common Equity | 36.30% | 348.54% | 337.83% | 213.53% | -63.02% |
Total Preferred Equity | -50.77% | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -44.67% | 750.44% | 689.60% | 539.91% | 427.83% |
|